SCHEMBL6652253

SCHEMBL6652253

c1cnc2cc(OCCCN3CCOCC3)ccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 3/20 0.58
FGFR1 P11362 2/20 0.57
SRC P12931 2/20 0.57
HRH3 Q9Y5N1 4/20 0.56
ALDH1A1 P00352 4/20 0.56
MAPK1 P28482 2/20 0.56
CYP1A2 P05177 1/20 0.56
CHRM2 P08172 1/20 0.56
CHRM1 P11229 1/20 0.56
HTR2A P28223 1/20 0.56
SCN1A P35498 1/20 0.56
HTR2B P41595 1/20 0.56
KCNH2 Q12809 1/20 0.56
SCN2A Q99250 1/20 0.56
SIGMAR1 Q99720 1/20 0.56
SCN3A Q9NY46 1/20 0.56
USP2 O75604 1/20 0.54
LMNA P02545 1/20 0.54
HRH1 P35367 1/20 0.54
GRM4 Q14833 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30997262 0.88 HRH3 (0.61) DRD3HRH3HRH1KDM4E
SCHEMBL9825515 0.86 DRD3 (0.66) DRD3HRH3HTR2AHRH1
SCHEMBL19689597 0.85 DRD3 (0.58) DRD3HRH3HRH1
SCHEMBL9826117 0.84 DRD3 (0.76) DRD3HRH3MAPK1CYP1A2HTR2A
SCHEMBL30979868 0.81 HRH3 (0.54) FGFR1SRCHRH3ALDH1A1MAPK1
SCHEMBL29464187 0.81 DRD3 (0.62) DRD3HRH3HRH1
SCHEMBL29464188 0.81 DRD3 (0.62) DRD3HRH3HRH1
SCHEMBL3067381 0.81 HRH3 (0.54) FGFR1SRCHRH3ALDH1A1MAPK1
SCHEMBL9825963 0.81 SLC6A4 (0.73) DRD3HRH3HTR2AHRH1
Hydrochloric Acid SCHEMBL9826980 0.80 SLC6A4 (0.71) DRD3HRH3HTR2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397364-A1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS ELI LILLY AND COMPANY (US) 2004-03-17 EP disclosed
WO-2002094833-A1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS ELI LILLY AND COMPANY (US) 2002-11-28 WO disclosed